Oxford Asset Management’s Day One Biopharmaceuticals DAWN Stock Holding History

Oxford Asset Management’s Portfolio DAWN Stock Details DAWN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-99,747	Closed	-$2.14M	–	438
2026 Q1	$2.14M	Buy	+99,747	New	+$1.41M	0.86%	12
2025 Q4	–	Sell	-38,463	Closed	-$271K	–	562
2025 Q3	$271K	Buy	+38,463	New	+$265K	0.09%	360
2024 Q4	–	Sell	-11,157	Closed	-$155K	–	488
2024 Q3	$155K	Buy	+11,157	New	+$159K	0.13%	261

Other funds holding DAWN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Oxford Asset Management's DAWN Position: Q2 2026 in Review

Oxford Asset Management sold out of Day One Biopharmaceuticals (DAWN) in Q2 2026, closing a stake of 99,747 shares — an estimated $2.14M sold.

Oxford Asset Management first reported a position in DAWN in Q3 2024 and held it in 3 quarters. The position peaked at $2.14M in Q1 2026. 1 fund tracked by Wall St. Rank holds DAWN as of Q2 2026.

Oxford Asset Management reported no remaining Day One Biopharmaceuticals position as of Q2 2026 after selling out during the quarter.
Oxford Asset Management sold 99,747 Day One Biopharmaceuticals shares in Q2 2026, an estimated $2.14M.
Oxford Asset Management first reported a position in Day One Biopharmaceuticals in Q3 2024 and held it in 3 quarters.
Oxford Asset Management's Day One Biopharmaceuticals position peaked at $2.14M in Q1 2026.
1 fund tracked by Wall St. Rank held Day One Biopharmaceuticals as of Q2 2026.

Based on Oxford Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.